An Open-Label, Dose-Escalation Study on the Safety, Tolerability and Preliminary Efficacy for Preventing SAP by Intravenous Pump-Delivered Propranolol in Patients With ICH

NCT07528235 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Intracerebral Hemorrhage
Stroke-Associated Pneumonia (SAP)

Interventions

DRUG: Intravenous Pump-Delivered Propranolol

Sponsor

Tang-Du Hospital